Legislative record

119-HR2450FEDERALIn Committee

Prescription Drug Transparency and Affordability Act

Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Voted 3/27/2025View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.